NCT06276673

Brief Summary

The purpose of this study is to investigate the use of single (SC) and multi-chamber (MC) blood flow restriction (BFR) cuff exercise on indices of arterial stiffness, muscle morphology, and participant perception.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
35

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 13, 2024

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

February 17, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

February 26, 2024

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 10, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 10, 2024

Completed
Last Updated

February 26, 2024

Status Verified

February 1, 2024

Enrollment Period

9 months

First QC Date

February 17, 2024

Last Update Submit

February 17, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Arterial Stiffness

    A measurement of vascular health.

    Prior to and 10-minutes after the exercise intervention

  • Muscle Morphology

    A measurement of vastus lateralis cross sectional area

    Prior to and immediately after the exercise intervention

Study Arms (3)

single chamber blood flow restriction cuff

EXPERIMENTAL

Single Chamber BFR (Delfi, Vancouver, Canada) training devices will be used for exercise and testing sessions (see attachment). Cuffs will be placed around the right and left proximal thigh. The LOP will be set at 60% immediately before exercise and will be applied during the entire exercise set (approximately 30-60 seconds in duration) in accordance with manufacturer specifications. The cuffs will maintain pressure during training and rest periods. The LOP will be decreased to 0% immediately after the set is completed.

Device: Delfi

Multiple chamber blood flow restriction cuff

EXPERIMENTAL

Multiple chamber BFR (B-Strong, Park City, UT) training devices will be used for exercise and testing sessions (see attachment). Cuffs will be placed around the right and left proximal thigh. The LOP will be set at 60% immediately before exercise and will be applied during the entire exercise set (approximately 30-60 seconds in duration) in accordance with manufacturer specifications. The cuffs will maintain pressure during training and rest periods. The LOP will be decreased to 0% immediately after the set is completed.

Device: Delfi

No BFR cuff

PLACEBO COMPARATOR

No cuff will be worn during the training session.

Device: Delfi

Interventions

DelfiDEVICE

Cuffs will be worn throughout the entire training session. Training session consist of lower intensity wall squats. Four sets of wall squats will be performed to failure. Arterial stiffness and muscle morphological assessments will be conducted before and after the exercise.

Also known as: B-Strong
Multiple chamber blood flow restriction cuffNo BFR cuffsingle chamber blood flow restriction cuff

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Physically active (\> 1,000 MET/min/wk) for at least six months.
  • Weight stable for previous 6 months (+/-2.5 kg)
  • Female subjects only- reported regular menstrual cycles for the last 2 years

You may not qualify if:

  • BP\>140/90 mmHg
  • BMI\>40 kg/m2
  • Diabetes
  • Familial hypercholesterolemia
  • Past or current history of CHD, stroke or major CVD events. Respiratory diseases (not including asthma), endocrine or metabolic, neurological, or hematological disorders that would compromise the study or the health of the subject.
  • Women must not be pregnant, plan to become pregnant during the study, or be nursing
  • Active renal or liver disease
  • All medications and supplements that influence dependent variables\*
  • Recent surgery \< 2 months
  • Alcohol abuse
  • Sleep apnea
  • Claustrophobia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Salisbury University

Salisbury, Maryland, 21801, United States

Location

Related Publications (1)

  • Rolnick N, de Queiros VS, Moghaddam M, Peikon E, Taylor S, Watson S, Ruffhead C, Zupnik S, Werner T. Cardiovascular, perceptual, and performance responses to single- vs. multi-chambered blood flow restriction cuffs. Front Sports Act Living. 2024 Nov 14;6:1469356. doi: 10.3389/fspor.2024.1469356. eCollection 2024.

MeSH Terms

Conditions

Vascular Diseases

Condition Hierarchy (Ancestors)

Cardiovascular Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Unable to blind due to differences in cuff size and appearance.
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: Participants will undergo three treatment sessions (control (no BFR), SC BFR, and MC BFR) in a randomized order separated by one week.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

February 17, 2024

First Posted

February 26, 2024

Study Start

February 13, 2024

Primary Completion

November 10, 2024

Study Completion

December 10, 2024

Last Updated

February 26, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will share

The plan is to share data when requested

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
Data will be shared after study is published for five years.

Locations